Process for the preparation of 4- {4-[({[4 -chloro-3 -(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3fluorophenoxy}-N-methylpyridine-2-carboxamide, its salts and monohydrate

Details for Australian Patent Application No. 2011240113 (hide)

Owner Bayer Pharma Aktiengesellschaft

Inventors Stiehl, Juergen; Heilmann, Werner; Logers, Michael; Rehse, Joachim; Gottfried, Michael; Wichmann, Saskia

Agent Davies Collison Cave

Pub. Number AU-A-2011240113

PCT Pub. Number WO2011/128261

Priority 10004022.9 15.04.10 EP

Filing date 8 April 2011

Wipo publication date 20 October 2011

International Classifications

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

11 October 2012 PCT application entered the National Phase

  PCT publication WO2011/128261 Priority application(s): WO2011/128261

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011240122-Kerbstone and stop for bus traffic

2011240102-Very low-dosed solid oral dosage forms for HRT